title: Multifaceted approach to medication use policy development: the restriction of meperidine.
abstract: As institutions continue to expand their drug policy development efforts in order to improve care and reduce cost, the use of multifaceted approaches offer several benefits. Population data on drug use support the need for policy action. The use of institutional outcomes data in conjunction with published evidence augments the process, and the consensus approach to guideline development engenders medical staff support. Such efforts, however, require significant dedication of human resources. Institutions with limited personnel to allocate to drug policy activities may consider increasing the depth of their efforts (using a multifaceted approach) while limiting the breadth of their efforts (only attempting one or two major targets per year, and doing them well).
authors.affiliation: Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison 53792, USA.
authors.forename: L C
authors.initials: LC
authors.lastname: Vermeulen
authors.forename: K A
authors.initials: KA
authors.lastname: Bollinger
authors.forename: J
authors.initials: J
authors.lastname: Antonopoulos
authors.forename: P D
authors.initials: PD
authors.lastname: Meek
authors.forename: L M
authors.initials: LM
authors.lastname: Goshman
authors.forename: P A
authors.initials: PA
authors.lastname: Ploetz
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use*; D017723:Drug Utilization Review; D006785:Hospitals, University; D006801:Humans; D008614:Meperidine / Q000009:adverse effects / Q000627:therapeutic use*; D016134:Organizational Policy; D010146:Pain / Q000188:drug therapy; D010607:Pharmacy Service, Hospital / Q000592:standards*; D010606:Pharmacy and Therapeutics Committee; D017410:Practice Guidelines as Topic; D014922:Wisconsin